Endeavor BioMedicines is a biotechnology company that is striving to discover new ways to treat patients who have life-threatening diseases. The company is working toward that goal by aiming to combat the drivers of fibrosis and oncology, which are both areas of medicine that have unmet needs. Endeavor BioMedicines was founded in 2018 by John Hood and Miguel de los Rios and is headquartered in San Diego, CA. In addition to looking for treatments that alleviate symptoms, Endeavor BioMedicines is seeking ways to reverse the effects of terminal illnesses.

Register for Details

For more details on financing and valuation for Endeavor BioMedicines, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Endeavor BioMedicines

Forge green plus iconForge green minus icon

What is Endeavor BioMedicines's IPO price?

The IPO price for Endeavor BioMedicines will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Endeavor BioMedicines?

Endeavor BioMedicines is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Endeavor BioMedicines shares pre-IPO?

If you own Endeavor BioMedicines pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Endeavor BioMedicines a publicly traded company?

Endeavor BioMedicines is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Endeavor BioMedicines's funding to date?

Endeavor BioMedicines has raised $163MM to date.
Forge green plus iconForge green minus icon

When was Endeavor BioMedicines founded?

Endeavor BioMedicines was founded in 2018.

Who are Endeavor BioMedicines's major investors?

Fidelity Management & Research
T. Rowe Price
Longitude Capital
Perceptive Advisors
Woodline Partners
The Invus Group
Ally Bridge Group
Avidity Partners
Piper Sandler
SymBiosis Capital Management
Revelation Partners
Omega Funds
Matrix Capital Management
Silver Arch Bio
Velosity Capital

Endeavor BioMedicines Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
2/7/2022 Series B $101MM raised $XXX.XX $XXX.XX
1/7/2021 Series A-1, A-2 and A-3 $62MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.